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Renal Doppler resistance indices are associated with systemic
atherosclerosis in kidney transplant recipients.
Background. In kidney transplant recipients, increased in-
trarenal resistance indices measured by duplex ultrasound are
associated with poor subsequent allograft performance. It re-
mains unclear whether high resistance indices rather reflect lo-
cal renal damage or systemic vessel disease. We hypothesized
that resistance indices are associated with cardiovascular risk
factors and with subclinical systemic atherosclerosis in trans-
plant recipients.
Methods. In 105 renal transplant recipients, categories of risk
for coronary heart disease were determined by Framingham risk
scoring. Intrarenal resistive index (RI) and pulsatility index (PI)
were measured in segmental arteries at five representative lo-
cations. For assessment of subclinical atherosclerosis, common
carotid intima-media thickness, and ankle-brachial blood pres-
sure index (ABI) were determined.
Results. Transplant recipients with high coronary risk had
higher intrarenal resistance indices than low-risk patients.
Higher age, female gender, and lower body mass index were in-
dependently associated with increased resistance indices. Renal
resistance indices were correlated with common carotid intima-
media thickness [RI: r = 0.270 (P = 0.005); PI: r = 0.355 (P <
0.001)]. This association remained significant after adjusting for
renal function. Renal resistance indices were increased in pa-
tients with pathologic ankle-brachial-indices compared to pa-
tients with physiologic ankle-brachial-indices [RI: 73.3 ± 7.1 vs.
70.2 ± 6.9 (P = 0.03); PI: 146.4 ± 29.9 vs. 131.4 ± 25.9 (P =
0.01)]. Renal resistance indices were neither significantly cor-
related with glomerular filtration rate (GFR), nor with donor
age.
Conclusion. Intrarenal resistance indices are a complex inte-
gration of arterial compliance, pulsatility, and peripheral resis-
tance. They are associated with traditional cardiovascular risk
factors as well as with subclinical atherosclerotic vessel dam-
age and should thus not be considered specific markers of renal
damage.
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Renal resistance indices (RIs) measured by duplex ul-
trasound have recently been shown to be associated with
long-term allograft and patient survival in kidney trans-
plant recipients. In a prospective cohort study reported by
Radermacher et al [1], a resistive index of 80 or higher in
a kidney transplant was a stronger predictor of allograft
loss than various established risk factors such as protein-
uria, donor age, or the number of human leukocyte anti-
gen (HLA) mismatches. Increased RIs were suggested to
reflect a nonspecific renal scarring process resulting in a
reduction of the intrarenal vessel area and a subsequent
increase in intrarenal vascular resistance (compare [2]).
However, ultrasound resistance indices do not directly
reflect renovascular resistance. As discussed by Rader-
macher et al [1], additional intrarenal and extrarenal
hemodynamic factors have a major impact on the RI in
the allograft.
First, in cross-sectional studies among transplant re-
cipients, ultrasound RIs significantly depend on the pulse
pressure, which is the difference between systolic and di-
astolic blood pressure, and on the age of the transplant
recipient, whereas neither donor age nor serum creati-
nine nor creatinine clearance independently predict RIs
[3, 4]. Second, ex vivo data suggest that ultrasound RIs
are affected by pulse pressure and by vascular compli-
ance independently from renal vascular resistance [5–7].
Finally, a recent hemodynamic study surprisingly found a
significant negative correlation between ultrasound RIs
and hemodynamically assessed renal vascular resistance
in renal transplant recipients before and after angioplasty
and stenting of transplant artery stenosis [8].
We thus hypothesized that ultrasound renal RIs in sta-
ble transplant recipients, instead of representing selective
markers of local kidney damage, are significantly associ-
ated with cardiovascular risk factors as well as with sub-
clinical atherosclerotic disease in nonrenal organs.
METHODS
Subjects
After allogenic renal transplantation, 105 patients
(60 male and 45 female) were studied between
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September 2003 and July 2004. All patients had been
transplanted for at least 6 months (mean 83 ± 64 months,
range 6 to 237 months) and were being followed by our
outpatient clinic. Patients with rapid deterioration of re-
nal function (increase in serum creatinine >0.8 mg/dL
within 28 days), with hydronephrosis of grade 2 or higher
or with angiographically proven, untreated renal artery
stenosis resulting in a 50% reduction in the luminal di-
ameter were excluded.
All patients gave informed consent. Ultrasonography
and data acquisition were performed by a single investi-
gator who was blinded for the study hypothesis (M.K.G.).
At study entry, blood was taken from all subjects under
standardized conditions. Plasma glucose, creatinine, total
cholesterol, low-density lipoprotein (LDL), high-density
lipoprotein (HDL), C-reactive protein (CRP), lipopro-
tein(a), and homocysteine were obtained using standard
techniques. Adjusted estimated glomerular filtration rate
(GFR) was calculated using the Modification of Diet
in Renal Disease (MDRD) Study equation 3 [9]. Pro-
teinuria was measured in morning specimens, using the
protein-to-creatinine ratio [9]. According to the National
Kidney Foundation-Dialysis Outcomes Quality Initiative
(K-DOQI) guidelines [9], proteinuria was diagnosed in
patients with a protein-to-creatinine ratio >200 mg/g.
Anthropomorphic measurements were recorded, and
body mass index (BMI) was calculated as weight
(kg)/height (m)2. Systolic blood pressure(RRsys), dias-
tolic blood pressure (RRdia), and heart rate were mea-
sured after 5 minutes of rest. Mean arterial blood pressure
(RRmean) was calculated as RRdia + [(RRsys − RRdia)/3].
Assessment of cardiovascular risk factors
and comorbidity
A standardised questionnaire was used to record a his-
tory of smoking, diabetes, a family history of premature-
onset cardiovascular disease (defined as myocardial
infarction or stroke by age 65 in first-degree relatives),
current drug intake, and cardiovascular comorbidity. Ad-
ditionally, comorbidity was assessed by chart review.
Coronary artery disease was diagnosed in patients who
had had a myocardial infarction or who had under-
gone coronary artery angioplasty, stenting, and/or bypass
surgery. In patients who had had a stroke or had under-
gone carotid endarterectomy or stenting, cerebrovascular
disease was diagnosed. Finally, in patients who had under-
gone nontraumatic lower extremity amputation, lower
limb artery angioplasty, stenting and/or bypass surgery,
peripheral artery disease was diagnosed. Patients were
defined as having cardiovascular disease if they had coro-
nary artery disease, cerebrovascular disease, and/or pe-
ripheral artery disease.
Patients with self-reported diabetes mellitus, with a
nonfasting blood sugar level of >200 mg/dL, with a fast-
ing blood sugar lever of >126 mg/dL, or with current use
of hypoglycemic medication were categorized as diabetic.
Patients were categorized as active smokers if they were
current smokers or had stopped smoking <1 month be-
fore entry into the study.
Categories of risk for coronary heart disease were de-
termined by Framingham risk scoring. A 10-year risk
for myocardial infarction and coronary death were de-
termined using electronic calculators, which are avail-
able on the adult treatment panel (ATP) III page of
the National Heart, Lung, and Blood Institute Web site
(www.nhlbi.nih.gov/guidelines/cholesterol). According to
the Third Report of the National Cholesterol Education
Program (NCEP), patients with a Framingham risk score
of >20%, with prevalent cardiovascular disease (as de-
fined above), or with diabetes mellitus were classified to
have “high coronary heart disease risk” (10-year coro-
nary heart disease risk >20%) [10]. Accordingly, patients
with a 10-year coronary heart disease risk of 10% to
20% and of <10% according to the Framingham score
were defined to have “intermediate coronary heart dis-
ease risk” and “low coronary heart disease risk,” respec-
tively.
Renal RIs
Color Doppler examinations were performed with a
phased-array transducer (Acuson Sequoia, Mountain-
view, CA, USA), B-mode frequency 5 MHz; Doppler fre-
quency 2.5 MHz in supine position.
Intrarenal Doppler spectra were obtained from the
segmental arteries at five representative locations, and
the RI and pulsatility index (PI) were calculated accord-
ing to the following formula:
RI = (peak systolic frequency shift
−minimum diastolic frequency shift)/
peak systolic frequency shift
PI = (peak systolic frequency shift
−minimum diastolic frequency shift)/
mean frequency shift
The average RI and PI were computed to yield an over-
all RI and PI for the renal transplant.
A subgroup of 32 patients had taken part in an ultra-
sound study performed 4 years earlier by us [11]. Present
and former RI and PI measurements were compared in
order to assess the stability of renal RIs over time.
Interobserver variability between the two investigators
who had performed the ultrasound examinations in the
present cohort (M.K.G.) and in the earlier study (G.H.H.)
was assessed in a subgroup of 16 patients, in whom resis-
tance indices were measured within 1 hour by both inves-
tigators in a blinded fashion. The mean differences in RI
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Table 1. Linear regression models of the association of cardiovascular risk factors and renal resistive indices (RI)
Model 1 Model 2
B SD P value B SD P value
Constant 77.058 6.537 <0.001 80.953 6.586 <0.001
Age years 0.229 0.048 <0.001 0.237 0.047 <0.001
Diabetes mellitus yes 2.084 1.482 0.163 1.739 1.454 0.235
Active smoking yes −1.319 1.524 0.389 −1.217 1.488 0.416
Gender recipient male −4.425 1.270 0.001 −4.926 1.258 <0.001
Mean arterial blood pressure mm Hg −0.059 0.058 0.313 −0.070 0.057 0.220
Pulse pressure mm Hg 0.040 0.041 0.337 0.053 0.040 0.197
High-density lipoprotein mg/dL −0.024 0.033 0.472 −0.013 0.033 0.685
Low-density lipoprotein mg/dL −0.008 0.017 0.635 −0.015 0.017 0.383
Body mass index kg/m2 −0.368 0.148 0.014 −0.374 0.144 0.011
Family history yes 1.568 1.273 0.221 1.494 1.243 0.233
Indicated are regression coefficients (B), their standard deviation (SD), and the level of significance (P value).
and PI measurements between both observers were 2.7
± 2.3 and 13.6 ± 10.4, respectively.
Carotid ultrasound studies
The intima-media thickness of the common carotid
artery was measured from high-resolution, two-
dimensional ultrasound images obtained by a linear-
array 8 MHz transducer (Acuson Sequoia). With the
subject in supine position and the head slightly extended
and turned to the opposite direction, the distal common
carotid artery and the carotid bulb were identified
by longitudinal scanning. Intima-media thickness was
defined as the distance between the leading edges of the
lumen interface and the media-adventitia interface of
the far wall.
Three representative intima-media thickness measure-
ments were bilaterally performed in the far wall of the
common carotid arteries at fixed positions (1.0, 1.5, and
2.0 cm proximal to the bifurcation), and these six intima-
media thickness readings were averaged to give the mean
common carotid intima-media thickness (intima-media
thickness mean). Intima-media thickness was not mea-
sured at the site of a carotid plaque.
Ankle-brachial blood pressure index (ABI)
Arm blood pressure (brachial artery) and bilateral an-
kle blood pressure (posterior tibial artery), measured by
hand-held Doppler (Handydop, Elcat, Wolfratshausen,
Germany), were taken with the subject supine. ABI was
calculated by the ratio of the ankle systolic pressure di-
vided by the arm systolic pressure. The systolic pressure
of the arm without dialysis access and the lower value of
the ankle pressure were used for the calculation.
Participants who had an ABI<1.10 were categorized as
having low ABI. Participants were categorised as having
high ABI if they had an ABI measure >1.40 or if the ankle
pressure of either leg could not be obtained because of
arterial stiffening (pulse could not be obliterated with
a pressure of >300 mm Hg). Participants were defined
as having normal ABI if ABI measures were >1.10 and
<1.40.
Statistics
Data management and statistical analysis were
performed with the Prism 4.00 statistical software
(Graphpad, San Diego, CA, USA). Unless indicated
otherwise, continuous data are expressed as means ±
standard deviation, and compared by Mann-Whitney U
test, or by Kruskal-Wallis test followed by Dunn’s post
hoc test, as appropriate.
For analyzing the association of traditional cardiovas-
cular risk factors with renal RIs, continuous data first were
categorized into tertiles. Subsequently, a multivariate lin-
ear regression analyses were used to determine indepen-
dent predictors of intrarenal RIs. Model 1 included all
traditional cardiovascular risk factors listed in Table 1.
Model 2 additionally included the GFR.
Correlation coefficients were calculated by Spearman
test. The level of significance was set at P < 0.05.
RESULTS
Patient characteristics
Among the 105 patients included, mean age was 52.5
± 14.4 years, and mean serum creatinine was 1.7 ±
0.7 mg/dL. Twenty-seven patients suffered from diabetes
mellitus and 20 patients were active smokers, as defined
above.
As immunosuppressive medication, patients received
cyclosporine A (N = 61) or tacrolimus (N = 41). Three
patients had no calcineurin inhibitor. Coimmunosuppres-
sive medication comprised azathioprine (N = 31), my-
cophenolate mofetil (N = 7), and methylprednisolone
(N = 86). Intrarenal resistance indices did not signifi-
cantly differ between patients on cyclosporine A and on
tacrolimus treatment (cyclosporine A RI 72.8 ± 7.2 and
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PI 144.5 ± 30.4; tacrolimus RI 71.3 ± 7.1 and PI 132.7 ±
26.0). Mean donor age was 42.5 ± 16.8 years. There was
no significant correlation between intrarenal resistance
indices and donor age [RI: r = 0.20 (P = 0.09); PI: r =
0.17 (P = 0.16)].
Association between cardiovascular risk factors
and renal RIs
According to the Framingham risk score, 46 patients
had “high coronary heart disease risk” (10-year coronary
heart disease risk >20%), 13 patients had “intermedi-
ate coronary heart disease risk” (10-year coronary heart
disease risk 10% to 20%), and 46 patients had “low coro-
nary heart disease risk” (10-year coronary heart disease
risk <10%). Intrarenal RIs significantly differed between
these three groups and high-risk patients had significantly
higher RIs than low-risk patients (Fig. 1).
For analyzing the impact of traditional cardiovascular
risk factors on RIs, continuous data were categorized into
tertiles. High intrarenal RIs were associated with a pulse
pressure >60 mm Hg, with age >60 years, with the pres-
ence of diabetes mellitus, with female gender, and with
smoking abstinence. Neither LDL, nor HDL cholesterol
levels, nor mean blood pressure had an impact on in-
trarenal RIs (Fig. 1). Among nontraditional cardiovascu-
lar risk factors, neither lipoprotein(a), nor homocysteine,
nor CRP were associated with intrarenal RIs (data not
shown).
A subsequent multivariate linear regression analysis,
which included all traditional cardiovascular risk factors,
showed that older age, female gender, and lower BMI
were associated with higher intrarenal RIs (RI model 1).
These associations remained significant after further ad-
justment for renal function (model 2).
Stability of RIs over time
Of the present cohort, 32 patients had taken part in
an earlier ultrasound study [11]. The mean time interval
between the two ultrasound examinations was 3.4 ± 0.2
years. As depicted in Figure 2, renal RIs remained re-
markably stable over time, with a mean yearly increase
in absolute RI and PI values of 0.2 ± 1.8 and 1.0 ± 7.1,
respectively.
Association between markers of subclinical
atherosclerosis and renal RIs
Renal RIs were significantly correlated with common
carotid intima-media thickness (Fig. 3). In contrast, no
significant correlation was found between renal function,
described as calculated GFR, and intima-media thickness
measurements [r = −0.008 (P = 0.932)]. The association
between renal RIs and intima-media thickness remained
significant after adjusting for GFR in a multivariate linear
regression analysis (data not shown).
Renal RIs were significantly increased in patients with
pathologic ABI compared to patients with physiologic
ABI [RI: 73.3 ± 7.1 vs. 70.2 ± 6.9 (P = 0.03); PI: 146.4 ±
29.9 vs. 131.4 ± 25.9 (P = 0.01)]. When patients with
pathologically decreased and patients with pathologically
increased ABI were regarded separately, a significant dif-
ference remained for intrarenal PIs, but not for intrarenal
RIs (Fig. 4).
Association between renal RIs and transplant function
Renal RI did not significantly correlate with the GFR
(Fig. 5A). In contrast, a significant correlation was found
between length of the transplant, as assessed sonograph-
ically, and renal RIs (Fig. 5B). Patients with proteinuria
tended to have higher RIs than patients without protein-
uria [RI: 74.0 ± 7.9 vs. 71.0 ± 6.8 (P = 0.08); PI: 149.2 ±
34.7 vs. 134.0 ± 25.8 (P = 0.07)].
DISCUSSION
Duplex ultrasound with measurement of intrarenal
RIs has originally been introduced in kidney transplant
medicine for early diagnosis of acute allograft rejection
[12, 13]. However, later studies cast doubt on the sen-
sitivity and specificity of RIs in discriminating different
causes of acute allograft dysfunction, as summarized by
Dupont et al [14].
Recently, intrarenal RIs have been suggested to be as-
sociated with long-term allograft and patient survival in
kidney transplant recipients. Radermacher et al [1] re-
ported a RI of 80 or higher to be the strongest predictor
of allograft loss among some 44 risk factors included in a
multivariate analysis, and RIs were correlated with sev-
eral histologic markers of intrarenal damage [1, 2].
Again, however, the specificity of intrarenal RIs for
selective assessment of intrarenal damage remains un-
certain, as discussed by Radermacher et al [1]. Earlier
models considered ultrasound RI and PI to directly re-
flect intrarenal resistance due to, for example, a reduction
in the intrarenal vessel area [15], and the terms “resistive
index” and “renal vascular resistance” have been used
interchangeably by some authors. We however came to
learn recently that the ultrasound RI is a complex com-
posite ratio that represents a number of vascular factors
and that predominantly reflects arterial compliance and
pulsatility rather than renal vascular resistance [16].
Bude and Rubin [6] constructed an in vitro model
in which changes in vascular compliance and vascular
resistance were analyzed separately. They found ultra-
sound RIs to be dependent on both vascular compliance
and vascular resistance, becoming less and less depen-
dent on resistance as compliance decreased, and being
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Fig. 1. Intrarenal resistive indices (RI) and pulsatility indices (PI) in renal transplant recipients categorized according to Framingham risk scores
and to traditional cardiovascular risk factors. Indicated are the mean and the standard error of the mean. Abbreviations are: CHD, coronary heart
disease; RR mean, mean arterial blood pressure; PP, pulse pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; DM, diabetes
mellitus; CVD, cardiovascular disease; BMI, body-mass index.
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Fig. 2. Stability of intrarenal resistive indices (RI) and pulsatility indices (PI) over time in a subgroup of 32 patients. Measurements taken in the
present study are compared to measurements taken in an ultrasound study 4 years earlier.
completely independent of vascular resistance when com-
pliance was zero. In an in vivo model of acute urinary
obstruction in Yorkshire pigs, Claudon et al [17] showed
ultrasound RI to correlate well with ureteral pressure and
with renal perfusion pressure, but poorly with vascular re-
sistance. Finally Tublin, Tessler, and Murphy [5] reported
on an ex vivo study, in which rabbit kidneys were perfused
using a pulsatile perfusion system, and in which renal
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Fig. 3. Intrarenal resistive indices (RI) (A) and pulsatility indices (PI)
(B) are significantly correlated with common carotid intima-media
thickness (IMT). Indicated are the correlation coefficient (r) and the
level of significance.
vascular resistance, systolic, diastolic pressure, pulse pres-
sure, and pulse rate were controlled. The authors found
intrarenal resistance indices to rise only with marked,
likely nonphysiologic increases in renal vascular resis-
tance, whereas a linear relationship was shown between
pulse pressure and intrarenal RIs. Consequently, the ul-
trasound “resistance index” has recently been claimed
to be inappropriately named, and the term “impedance
index” has been suggested instead [6].
In agreement with such in vitro and animal data, an
association between ultrasound RIs and pulse pressure
has been reported before in renal transplant recipients
[3] and in hypertensive patients without impaired renal
function [18]. In addition, the impact of vascular com-
pliance and pulse pressure on ultrasound RIs helps to
explain why recent cross-sectional studies among renal
transplant recipients [3, 4, 11] found intrarenal RIs to sig-
nificantly correlate with recipient age, but not with donor
age, and why the intake of vasoconstrictive calcineurin
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Fig. 4. Intrarenal resistive indices (RI) and pulsatility indices (PI) in
renal transplant recipients with pathologically decreased ankle-brachial
index (ABI <1.1), with physiologicABI (1.1 to 1.4), and with patholog-
ically increased ABI (>1.4).
inhibitors does not result in an acute rise in ultrasound
RIs [11].
To our best knowledge, we are the first to show that
renal transplant recipients at high cardiovascular risk,
defined either by the Framingham risk score or by the
presence of subclinical atherosclerosis, have increased ul-
trasound RIs compared to low-risk patients even after
correction for transplant renal function. In contrast, we
found no significant correlation between renal RIs and
transplant function, which is in accordance with earlier
reports [3, 4]. The association between kidney length and
ultrasound RIs, which has not been reported before by
other groups, might be a play of chance, as we cannot
explain why kidney length rather than kidney function
correlates with RIs.
Thus, with regard to our hypothesis, ultrasound renal
RIs in stable transplant recipients do not represent selec-
tive markers of kidney damage, but are significantly asso-
ciated with systemic vascular risk factors as well as with
subclinical atherosclerotic disease in nonrenal organs.
A better understanding of the association between RIs
and transplant nephropathy might have been achieved
by correlating ultrasound measurements with histologic
findings from renal biopsies. However, we do not perform
routine renal biopsies in patients with stable transplant
renal function in our transplant center, and for ethical
reasons we decided not to undertake study biopsies.
The Framingham risk score has initially been estab-
lished and validated among apparently healthy individu-
als. Even though the absolute score may underestimate
cardiovascular risk in renal transplant recipients to a
certain degree, the Framingham risk score has convinc-
ingly been shown to discriminate cardiovascular high-risk
and low-risk transplant recipients [19]. When analyzing
individual traditional risk factors separately, ultrasound
RIs were significantly associated with older age, female
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Fig. 5. Renal length (B), but not glomerular filtration rate (A), are sig-
nificantly correlated with intrarenal resistive indices (RI) and pulsatility
indices (PI). Indicated are the correlation coefficient (r) and the level
of significance.
gender and lower BMI. The latter may be explained
by the small number of obese subjects among our pa-
tients (N = 9) and by the malnutrition-inflammation-
atherosclerosis syndrome (MIA syndrome), according to
which in patients with chronic renal disease, a low BMI,
reflecting malnutrition, is associated with systemic (mi-
cro)inflammation and accelerated atherogenesis [20].
As markers of subclinical atherosclerosis, the ABI and
common carotid intima-media thickness were measured
which allow a standardized and noninvasive assessment
of atherosclerotic vascular damage [21, 22].
In patients with intact renal function, renal RIs have
been associated with carotid atherosclerosis assessed as
carotid intima-media thickness [18, 23] or as carotid
plaque score [24].
CONCLUSION
Rather than being considered specific markers of re-
nal damage, intrarenal RIs are a complex integration of
arterial compliance, arterial pulsatility, and peripheral re-
sistance, which are associated with traditional cardiovas-
cular risk factors and with subclinical atherosclerosis. A
follow-up examination of our study cohort will have to
show in how far intrarenal RIs predict long-term prog-
nosis of kidney transplant recipients independently from
markers of subclinical atherosclerosis (e.g., intima-media
measurements).
In addition, future ultrasound studies will have to
examine whether intrarenal RIs may be corrected for
cardiovascular risk factors and for subclinical atheroscle-
rosis, in order to allow for a more specific assessment of
intrarenal damage. Finally, future studies should examine
in how far the specificity of transplant renal RIs might be
further increased by comparing transplant RIs to indices
measured in arteries of native (nonrenal) organs, such as
spleen arteries.
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